An interventional study of Esogastric pressure measurement in Neuromuscular Diseases, Congenital Diaphragmatic Hernia and Lung Diseases, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 0 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-04-03.
Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Neuromuscular Diseases by Assistance Publique - Hôpitaux de Paris — 3 open to participants now, 3 under way, none of them phase 3. Neuromuscular Diseases · Assistance Publique - Hôpitaux de Paris.
Among the 10 studies in Neuromuscular Diseases by Assistance Publique - Hôpitaux de Paris, this one is one of 2 that started in 2022, is one of 3 with no phase, and was the 5th registered.
361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.
Browse Neuromuscular Diseases studies →3 of the 10 studies in Neuromuscular Diseases by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 69 Neuromuscular Diseases studies recruiting now, 39 (57%) set no upper age limit and 22 (32%) stop at 75 or younger; 35 take children under 18; 16 take healthy volunteers.
This study: 0 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 2 started in 2022.
This study's planned enrollment of 550 is above the median of 30 across 204 interventional studies indexed under Neuromuscular Diseases.
Median enrollment 24 across the 4 interventional studies, 89 across the 6 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Neuromuscular Diseases by Assistance Publique - Hôpitaux de Paris, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Respiratory muscle testing allows a quantitative assessment of inspiratory and expiratory muscles in children of any age with primary or secondary respiratory muscle impairment, in order to better understand the pathophysiology of respiratory impairment and guide therapeutic management. The use of an invasive technique (esogastric probe) makes it possible to specifically explore the diaphragm, the accessory inspiratory muscles and the expiratory muscles in order to detect dysfunction or paralysis of these muscles, and to estimate the work of breathing in order to better guide the respiratory management.
The primary objective of the study is to evaluate the respiratory effort in children with primary or secondary impairment of the respiratory muscles during spontaneous breathing or during mechanical ventilation.
Respiratory muscle testing allows a quantitative assessment of inspiratory and expiratory muscles in children of any age with primary or secondary respiratory muscle impairment, in order to better understand the pathophysiology of respiratory impairment and guide therapeutic management. The use of an invasive technique (esogastric probe) makes it possible to specifically explore the diaphragm, the accessory inspiratory muscles and the expiratory muscles in order to detect dysfunction or paralysis of these muscles, and to estimate the work of breathing in order to better guide the respiratory management.
Respiratory muscle testing by means of esogastric measurements may allow assessing the effect of pharmacological treatment by comparing respiratory muscle strength before and after a few months with treatment. Moreover, esogastric measurements can be used to better adapt mechanical ventilation or to determine the possibility of weaning from the respiratory support.
The primary objective of the study is to evaluate the respiratory effort in children with primary or secondary impairment of the respiratory muscles during spontaneous breathing or during mechanical ventilation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Minor patients with primary or secondary impairment of respiratory muscles and followed at Necker Hospital
Other: Esogastric pressure measurement
Measurement of work of breathing and respiratory muscles strength using an esogastric catheter. One measurement or before and after (6 months and 1 year) the initiation of a pharmacological treatment in order to assess the effect of the treatment on respiratory muscle function.
Esophageal pressure-time product (PTPoes)
The integral of the esophageal pressure signal over inspiratory time
Time frame: Day 0
Diaphragmatic pressure-time product (PTPdi)
The integral of the transdiaphragmatic pressure signal over inspiratory time
Time frame: Day 0
Work of breathing (WOB)
Total work of breathing (WOBt) is calculated (in Joules/L) as the area under the pressure-volume curve, using the Campbell diagram. Elastic (WOBe) and resistive (WOBr) are estimated as the 2/3 and 1/3 of WOBt value, respectively.
Time frame: Day 0
Vital capacity
Vital capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation, using spirometry
Time frame: Day 0
Maximal respiratory static pressures
Maximal static inspiratory and expiratory airway pressures
Time frame: Day 0
Maximal sniff pressure
Airway pressure during a sniff test
Time frame: Day 0
Maximal whistle pressure
Airway pressure during a whistle test
Time frame: Day 0
Peak expiratory flow
Maximal flow during expiratory maneuver
Time frame: Day 0
Peak cough flow
Maximal flow during cough
Time frame: Day 0
Esophageal pressure during sniff
Esophageal pressure measurement during a sniff test
Time frame: Day 0
Gastric pressure during sniff
Gastric pressure measurement during a sniff test
Time frame: Day 0
Transdiaphragmatic pressure during sniff
Transdiaphragmatic pressure measurement during a sniff test
Time frame: Day 0
Crying transdiaphragmatic pressure
Transdiaphragmatic pressure measurement during crying in young children
Time frame: Day 0
Gastric pressure during cough
Gastric pressure measurement during a maximal cough maneuver
Time frame: Day 0
Twitch transdiaphragmatic pressure
Transdiaphragmatic pressure measurement during cervical magnetic stimulation
Time frame: Day 0
Inspiratory muscles tension-time index
Measurement of the tension-time index of the inspiratory muscles
Time frame: Day 0
Diaphragmatic tension-time index
Measurement of the tension-time index of the diaphragm
Time frame: Day 0
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with the disease severity
The pressure-time product of the respiratory muscles, the work of breathing and the respiratory muscle strength will be correlated with disease severity
Time frame: Day 0
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with polysomnography and gas exchange results
The pressure-time product of the respiratory muscles, the work of breathing and the respiratory muscle strength will be correlated with the polysomnography and gas exchange results
Time frame: Day 0
Esophageal pressure-time products in patients with any treatment and in patients with no treatment
The esophageal pressure-time product will be compared between patients with any treatment and patients receiving no treatment
Time frame: Day 0
The total work of breathing in patients with any treatment and in patients with no treatment
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, be compared between patients with any treatment and patients receiving no traeatment, using the Student t test
Time frame: Day 0
Measurement of esophageal pressure during a sniff in patients with any treatment and patients with no treatment
The esophageal pressure during a sniff will be compared between patients with any treatment and patients receiving no treatment
Time frame: Day 0
Measurement of the esophageal pressure-time product before and after pharmacological treatment
The esophageal pressure-time product will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Time frame: 6 months and 1 year after treatment initiation
The total work of breathing before and after pharmacological treatment
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation, using the ANOVA on repeated measures
Time frame: 6 months and 1 year after treatment initiation
Measurement of the esophageal pressure during a sniff before and after pharmacological treatment
The esophageal pressure during a sniff will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Time frame: 6 months and 1 year after treatment initiation
Measurement of transdiaphragmatic pressure during a sniff before and after pharmacological treatment
The transdiaphragmatic pressure measurement during a sniff will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Time frame: 6 months and 1 year after treatment initiation
Adaptation of the respiratory support according to the esophageal pressure-time product values
The esophageal pressure-time product will be measured to guide the respiratory support adaptation
Time frame: Day 0
Adaptation of the respiratory support according to the total work of breathing values
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be measured to guide the respiratory support adaptation
Time frame: Day 0
Measurement of the esophageal pressure-time product in patients with weaning success and in patients with weaning failure
The esophageal pressure-time product will be compared between patients with weaning success and weaning failure
Time frame: Day 0
Measurement of the total work of breathing in patients with weaning success and in patients with weaning failure
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be compared between patients with weaning success and weaning failure, using the Student t test
Time frame: Day 0
Measurement of the esophageal pressure during a sniff in patients with weaning success and in patients with weaning failure
The esophageal pressure during a sniff will be compared between patients with weaning success and weaning failure
Time frame: Day 0
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with the gas exchange during weaning trial
The pressure-time product, the work of breathing and the respiratory muscle strength will be correlated with the gas exchange during a weaning trial
Time frame: Day 0
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2022 (actual). Primary completion is estimated for Jan 2028, 72 months after the start.
Of 75 non-industry interventional studies with no phase under Neuromuscular Diseases, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 47. This study's planned 72 months is above that.
Counting every sponsor, half of 84 studies reached it within 25 months; a quarter within 12 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →